Publications by authors named "Anna Plotek"
Article Synopsis
- The study investigated the role of circulating angiogenic factors in patients with ischemic diabetic foot syndrome (DFS) to understand their relationship with clinical aspects and disease progression.
- The research found that higher levels of FGF-2, a pro-angiogenic factor, were linked to more severe ulcers and certain clinical parameters, such as age and blood cell counts.
- However, no significant connections were found between these angiogenic factors and microvascular health or glycemic control, highlighting the need for further research to solidify FGF-2's potential as a biomarker for ulcer progression in DFS.
Due to the fact that cardiovascular diseases (CVDs) have become the most serious problem in public health, there is a need for new and efficient methods for screening and early detection. In the recent literature, saliva and gingival crevicular fluid (GCF) have been gaining recognition as sources of many potential biomarkers of various systemic diseases, mainly because of correlation between the level of some compounds in the blood and saliva and association between the composition of saliva and health status. In this review, we summarize published findings of patients with atherosclerosis, arterial hypertension, coronary artery disease (CAD), acute coronary syndrome (ACS), and stroke in the context of clinical utility of saliva and GCF in diagnosing and assessing CVD severity.
View Article and Find Full Text PDFPeripheral arterial disease can involve tissue loss in up to 50% of patients with diabetic foot syndrome (DFS). Consequently, revascularization of narrowed or occluded arteries is one of the most common forms of comprehensive treatment. However, technically successful angioplasty does not always result in the healing of ulcers.
View Article and Find Full Text PDFBackground: The goal of secondary prevention is to hinder the recurrence of cardiovascular events in patients already diagnosed with cardiovascular diseases.
Aims: We aimed to assess the level of adherence to guidelines for secondary prevention of cardiovascular disease in everyday clinical practice.
Methods: This was a single‑center retrospective analysis of 460 consecutive rehospitalized patients previously diagnosed with coronary artery disease.
Comparison of clinical and echocardiographic outcomes and quality of life in patients with severe mitral regurgitation treated by MitraClip implantation or treated conservatively.
Postepy Kardiol Interwencyjnej
September 2018
Introduction: The most common alternative method of treatment for patients with severe mitral regurgitation (MR) is the implantation of a MitraClip device.
Aim: To evaluate clinical and echocardiographic outcomes and quality of life (QoL) in patients with severe secondary MR, disqualified from surgical intervention, treated by implantation of a MitraClip in comparison to conservative therapy.
Material And Methods: A total of 33 patients were included.